All
Rare Immune Cell May Predict Immunotherapy Response in Melanoma
January 18th 2024Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.